Search

Ocugen Inc

Închisă

1.5 1.35

Rezumat

Modificarea prețului

24h

Curent

Minim

1.48

Maxim

1.52

Indicatori cheie

By Trading Economics

Venit

-1.5M

-19M

Vânzări

1.7M

1.5M

EPS

-0.06

Marjă de profit

-1,250.946

Angajați

116

EBITDA

-987K

-17M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+548.99% upside

Dividende

By Acuity

Următoarele câștiguri

31 iul. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-61M

565M

Deschiderea anterioară

0.15

Închiderea anterioară

1.5

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 iul. 2026, 23:56 UTC

Correlated Moves

Costco Wholesale Corp's shares are lower in after-market hours, reflecting a slight decline since Monday's close amid broader market trends.

6 iul. 2026, 23:56 UTC

Biogen Inc. shares are higher in after-market trading, reflecting a slight upward movement since Monday's close and settling near the upper end of their one-month range.

6 iul. 2026, 23:56 UTC

ETF Constituents

SPDR S&P Regional Banking ETF shows gains in after-market trading, driven by contributions from Citizens Financial Group and East West Bancorp.

6 iul. 2026, 23:56 UTC

Correlated Moves
ETF Constituents

Vanguard Information Technology ETF shows little change in after-market trading, with top contributors AMD, Microsoft, and NVIDIA posting slight negative returns.

6 iul. 2026, 23:52 UTC

Correlated Moves
Social Media

Lam Research shares decline in after-market trading amid broader market weakness and recent insider selling of $11.70 million by Timothy Archer.

6 iul. 2026, 23:52 UTC

Mixed trading in European equity indices as Germany's DAX rises on strong factory orders, while FTSE 100 and CAC 40 dip amid disappointing retail sales and cautious ECB outlook.

6 iul. 2026, 23:52 UTC

Asia equity markets rise on tech sector optimism, while U.S. mega-cap stocks gain amid strong dollar and mixed European indices ahead of key economic data releases.

6 iul. 2026, 23:52 UTC

Global equity markets show mixed performance as U.S. and Asian indices rise while European stocks decline, amid varied economic data signaling resilience in services and manufacturing sectors.

6 iul. 2026, 23:52 UTC

U.S. equity markets remain flat post-holiday, with mega-cap tech stocks rising amid expectations of a Federal Reserve interest rate pause following a weak jobs report.

6 iul. 2026, 23:52 UTC

Japan's Household Spending Declines 0.4% YoY in May, Beating Expectations and Signaling Potential Recovery Amid Ongoing Inflation Pressures

6 iul. 2026, 23:52 UTC

Japan's Household Spending Surges 3.7% MoM in May, Exceeding Expectations and Indicating Consumer Confidence Recovery

6 iul. 2026, 23:52 UTC

China's June 2026 Inflation Rate Release Expected at 1.1% Amid Cautious Market Sentiment and Global Economic Influences

6 iul. 2026, 23:52 UTC

China's Producer Prices Expected to Rise 4.2% YoY Amid Inflationary Pressures and Strong Manufacturing Sentiment Ahead of July 9 Release

6 iul. 2026, 23:52 UTC

Initial Jobless Claims Expected at 220,000 Amid Rising Concerns Over Labor Demand and Economic Outlook

6 iul. 2026, 23:52 UTC

China's Inflation Rate Expected to Decrease Slightly by 0.002% in June Amid Global Economic Caution

6 iul. 2026, 23:52 UTC

Canada's Ivey PMI forecasted to rise to 59.1 amid recent economic contraction signals and geopolitical uncertainties impacting business confidence.

6 iul. 2026, 23:51 UTC

ETF Constituents
Macro News

Geopolitical tensions are driving modest gains for the Energy Select Sector SPDR Fund after-market hours, supported by positive contributions from Exxon Mobil and Chevron.

6 iul. 2026, 23:51 UTC

Kraft Heinz Co. shares are lower in after-market trading, reflecting routine movement amid a slight decline in U.S. services PMI and weaker job additions.

6 iul. 2026, 23:51 UTC

Fiserv Inc shares are higher in after-market trading, moving near the upper end of their one-month trading range. No specific news was identified for this increase.

6 iul. 2026, 23:51 UTC

Correlated Moves

Applied Materials shares are lower in after-market trading, continuing a trend of four consecutive sessions of losses amid broader market weakness and macroeconomic concerns.

6 iul. 2026, 23:46 UTC

Correlated Moves
ETF Constituents

Vanguard FTSE Europe ETF traded near unchanged levels in after-market hours, influenced by slight declines in top holdings SAP and BP.

6 iul. 2026, 23:46 UTC

Shares of Workday Inc. are lower in after-market trading. The U.S. services PMI fell to 54.0, indicating a slight slowdown in sector expansion.

6 iul. 2026, 23:46 UTC

Correlated Moves

U.S. services PMI fell to 54.0 in June, matching expectations. The Dow Jones Index is trading roughly flat amid cautious sentiment on Fed interest rates.

6 iul. 2026, 23:46 UTC

Intuitive Surgical shares are higher in after-market trading, continuing an upward trend from the previous three sessions. No specific news was identified for the move.

6 iul. 2026, 23:46 UTC

United States Oil Fund LP is trading higher in after-market hours, reflecting a recovery from earlier fluctuations amid mixed global equity performance.

6 iul. 2026, 23:41 UTC

Verisk Analytics Inc shares declined during after-market hours, despite a broader market context showing continued expansion in the services sector. No specific news was identified.

6 iul. 2026, 23:41 UTC

Correlated Moves

Vanguard Total International Bond ETF rises in after-market trading, reflecting positive bond market sentiment and stability near its one-month trading range.

6 iul. 2026, 23:41 UTC

Cognizant Technology Solutions shares are higher in after-market trading, amid broader market assessment of U.S. Services PMI and last week's nonfarm payrolls report.

6 iul. 2026, 23:41 UTC

Correlated Moves
Social Media
News

Micron Technology shares are lower in after-market trading, reflecting broader market pressures and concerns over a potential memory oversupply by 2028.

6 iul. 2026, 23:41 UTC

ETF Constituents

iShares MSCI Brazil ETF gains in after-market trading, supported by positive sentiment in global equity markets and contributions from PBR.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

548.99% sus

Prognoză pe 12 luni

Medie 9.67 USD  548.99%

Maxim 12 USD

Minim 7 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

6

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat